Mnk mediates integrin α6β4-dependent eIF4E phosphorylation and translation of VEGF mRNA

Molecular Cancer Research

Volumn 8, Issue 12, 2010, Pages 1571-1578

  Korneeva, Nadejda L ^a   Soung, Young Hwa ^a   Kim, Hong Im ^a   Giordano, Anthony ^b   Rhoads, Robert E ^a   Gram, Hermann ^c   Chung, Jun ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ALPHA6BETA4 INTEGRIN; CGP 57380; INITIATION FACTOR 4E; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN INHIBITOR; PROTEIN MNK1; PROTEIN SERINE THREONINE KINASE; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; RNA TRANSLATION; SIGNAL TRANSDUCTION; TRANSLATION REGULATION;

ANILINE COMPOUNDS; BUTADIENES; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CULTURE MEDIA, SERUM-FREE; DOWN-REGULATION; EUKARYOTIC INITIATION FACTOR-4E; HUMANS; INTEGRIN ALPHA6BETA4; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAP KINASE KINASE KINASES; NITRILES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN BIOSYNTHESIS; PROTEIN-SERINE-THREONINE KINASES; PURINES; RNA, MESSENGER; RNA, SMALL INTERFERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 78650438662     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-10-0091     Document Type: Article

References (40)

1. Mercurio AM, Bachelder RE, Rabinovitz I, O'Connor KL, Tani T, Shaw LM. The metastatic odyssey: The integrin connection. Surg Oncol Clin N Am 2001;10:313-28.
2. Mercurio AM, Rabinovitz I. Towards a mechanistic understanding of tumor invasion-lessons from the alpha6beta 4 integrin. Semin Cancer Biol 2001;11:129-41.
3. Lipscomb EA, Mercurio AM. Mobilization and activation of a signaling competent a6b4 integrin underlies its contribution to carcinoma progression. Cancer Metastasis Rev 2005;24:413-23.
4. Rabinovitz I, Toker A, Mercurio AM. Protein kinase C-dependent mobilization of the alpha6beta4 integrin from hemidesmosomes and its association with actin-rich cell protrusions drive the chemotactic migration of carcinoma cells. J Cell Biol 1999;146:1147-60.
5. Rabinovitz I, Tsomo L, Mercurio AM. Protein kinase C-alpha phosphorylation of specific serines in the connecting segment of the beta 4 integrin regulates the dynamics of type II hemidesmosomes. Mol Cell Biol 2004;24:4351-60.
6. Bon G, Folgiero V, Di Carlo S, Sacchi A, Falcioni R. Involvement of a a6b4 integrin in the mechanisms that regulate breast cancer progression. Breast Cancer Res 2007;9:203.
7. Bachelder RE, Crago A, Chung J, et al. Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. Cancer Res 2001;61:5736-40.
8. Chung J, Bachelder RE, Lipscomb EA, Shaw LM, Mercurio AM. Integrin (a6b4) regulation of eIF-4E activity and VEGF translation: A survival mechanism for carcinoma cells. Journal of Cell Biology 2002;158:165-74.
9. Haghighat A, Mader S, Pause A, Sonenberg N. Repression of capdependent translation by 4E-binding protein 1: Competition with p220 for binding to eukaryotic initiation factor-4E. EMBO J 1995;14:5701-9.
10. Kapp LD, Lorsch JR. The molecular mechanics of eukaryotic translation. Annu Rev Biochem 2004;73:657-704.
11. Graff JR, Zimmer SG. Translational control and metastatic progression: Enhanced activity of the mRNA cap-binding protein eIF-4E selectively enhances translation of metastasis-related mRNAs. Clin Exp Metastasis 2003;20:265-73.
12. Yoon S-O, Shin S, Lipscomb EA. A novel mechanism for integrinmediated ras activation in breast carcinoma cells: The alpha6beta4 integrin regulates ErbB2 translation and transactivates epidermal growth factor receptor/ErbB2 signaling. Cancer Res 2006;66:2732-9.
13. Fukunaga R, Hunter T. MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates. EMBO J 1997;16:1921-33.
14. Waskiewicz AJ, Flynn A, Proud CG, Cooper JA. Mitogen-activated protein kinases activate the serine/threonine kinasesMnk1 and Mnk2. EMBO J 1997;16:1909-20.
15. Rhoads RE. Minireview: Signal transduction pathways that regulate eukaryotic protein synthesis. J Biol Chem 1999;274:30337-40.
16. Pyronnet S, Imataka H, Gingras A-C, Fukunaga R, Hunter T, Sonenberg N. Human eukaryotic translation initiation factor 4G (eIF4G) recruits Mnk1 to phosphorylate eIF4E. EMBO J 1999;18:270-9.
17. Buxade M, Parra-Palau JL, Proud CG. The Mnks: MAP kinase-interacting kinases (MAP kinase signal-integrating kinases). Front Biosci 2008;13:5359-73.
18. Tuxworth WJJ, Saghir AN, Spruill LS, Menick DR, McDermott PJ. Regulation of protein synthesis by eIF4E phosphorylation in adult cardiocytes: The consequence of secondary structure in the 5'- untranslated region of mRNA. Biochem J 2004;378:73-82.
19. Topisirovic I, Ruiz-Gutierrez M, Borden KLB. Phosphorylation of the eukaryotic translation initiation factor eIF4E contributes to its transformation and mRNA transport activities. Cancer Res 2004;64:8639-42.
20. Orton K, Ling J, Waskiewicz AJ, et al. Phosphorylation of Mnk1 by caspase-activated Pak2/g-PAK inhibits phosphorylation and interaction of eIF4G with Mnk. J Biol Chem 2004;279:38649-57.
21. Rolfe M, McLeod L, Pratt PF, Proud CG. Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2). Biochem J 2005;388:973-84.
22. Mariappan MM, Senthil D, Natarajan KS, Choudhury GG, Kasinath BS. Phospholipase Cg-Erk axis in vascular endothelial growth factorinduced eIF4E phosphorylation and protein synthesis in renal epithelial cells. J Biol Chem 2005;280:28402-11.
23. Chrestensen CA, Shuman JK, Eschenroeder A, Worthington M, Gram H, Sturgill TW. MNK1 and MNK2 regulation in HER2-overexpressing breast cancer lines. J Biol Chem 2007;282:4243-52.
24. Wendel H-G, Silva RLA, Malina A, et al. Dissecting eIF4E action in tumorigenesis. Genes Dev 2007;21:3232-7.
25. Bianchini A, Loiarro M, Bielli P, et al. Phosphorylation of eIF4E by MNKs supports protein synthesis, cell cycle progression and proliferation in prostate cancer cells. Carcinogenesis 2008;29:2279-88.
26. Chrestensen CA, Eschenroeder A, Ross WG, et al. Loss of MNK function sensitizes fibroblasts to serum-withdrawal induced apoptosis. Genes Cells 2007;12:1133-40.
27. Dolniak B, Katsoulidis E, Carayol N, et al. Regulation of arsenic trioxide-induced cellular responses by Mnk1 and Mnk2. J Biol Chem 2008;283:12034-42.
28. Buxade M, Parra J, Rousseau S, et al. The Mnks are novel components in the control of TNF alpha biosynthesis and phosphorylate and regulate hnRNP A1. Immunity 2005;23:177-89.
29. Worch J, Tickenbrock L, Schwable J, et al. The serine-threonine kinase MNK1 is post-translationally stabilized by PML-RARalpha and regulates differentiation of hematopoietic cells. Oncogene 2004;23:9162-72.
30. Rowlett RM, Chrestensen CA, Nyce M, et al. MNK kinases regulate multiple TLR pathways and innate proinflammatory cytokines in macrophages. Am J Physiol Gastrointest Liver Physiol 2008;294: G452-9.
31. Shaw LM, Rabinovitz I, Wang HH, Toker A, Mercurio AM. Activation of phosphoinositide 3-OH kinase by the alpha6beta4 integrin promotes carcinoma invasion. Cell 1997;91:949-60.
32. Yan R, Rychlik W, Etchison D, Rhoads RE. Amino acid sequence of the human protein synthesis initiation factor eIF-4g. J Biol Chem 1992;267:23226-31.
33. Tesfay MZ, Yin J, Gardner CL, et al. Alpha/beta interferon inhibits capdependent translation of viral but not cellular mRNA by a PKRindependent mechanism. J Virol 2008;82:2620-30.
34. Waskiewicz AJ, Johnson JC, Penn B, Mahalingam M, Kimball SR, Cooper JA. Phosphorylation of the cap-binding protein eukaryotic translation initiation factor 4E by protein kinase Mnk1 in vivo. Mol Cell Biol 1999;19:1871-80.
35. Chung J, Mercurio AM. Contributions of the alpha6 integrins to breast carcinoma survival and progression. Mol Cells 2004;17:203-9.
36. Kim TH, Kim HI, Soung YH, Shaw LA, Chung J. Integrin (alpha6beta4) signals through Src to increase expression of S100A4, a metastasispromoting factor: Implications for cancer cell invasion. Mol Cancer Res 2009;7:1605-12.
37. Lodish HF. Model for the regulation of mRNA translation applied to haemoglobin synthesis. Nature 1974;251:385-8.
38. Rousseau D, Kaspar R, Rosenwald I, Gehrke L, Sonenberg N. Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E. Proc Natl Acad Sci U S A 1996;93: 1065-70.
39. Zhang M, Fu W, Prabhu S, et al. Inhibition of polysome assembly enhances imatinib activity against chronic myelogenous leukemia and overcomes imatinib resistance. Mol Cell Biol 2008;28:6496-509.
40. Chung J, KimTH. Integrin-dependent translational control: Implication in cancer progression. Microsc Res Tech 2008;71:380-6.